Verve Therapeutics
Jennifer Lavoie is director, CMC program management at Verve Therapeutics, where she leads the CMC team in ensuring program initiatives and goals are reached. She has extensive industry experience in various areas such as program/project management, regulatory affairs, and quality assurance. Most recently, she served as regulatory project manager for Akebia Therapeutics, where she was responsible for managing all aspects of regulatory submissions for their lead program as well as developing department unity for a newly created team. Ms. Lavoie received her B.S. in environmental science with a minor in chemistry from Franklin Pierce University.
This person is not in any teams
This person is not in any offices
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.